Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "expert"

1795 News Found

Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio
Biotech | April 09, 2026

Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio

The acquisition complements Gilead’s existing oncology expertise and development infrastructure


Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle
Healthcare | April 09, 2026

Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle

36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108


India Pharma 2026 to spotlight innovation, global partnerships in New Delhi
Policy | April 09, 2026

India Pharma 2026 to spotlight innovation, global partnerships in New Delhi

9th edition of flagship pharma conference to be held on April 13-14, bringing together policymakers, industry leaders and global stakeholders


Kokilaben hospital performs first remote robotic kidney surgery
Hospitals | April 09, 2026

Kokilaben hospital performs first remote robotic kidney surgery

Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat


OPPI partners with NIPER Raebareli to fund translational pharma research, build innovation talent
News | April 09, 2026

OPPI partners with NIPER Raebareli to fund translational pharma research, build innovation talent

Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem


mlHealth360, Madhya Pradesh Govt launch AI radiology pilot in 10 district hospitals
Digitisation | April 09, 2026

mlHealth360, Madhya Pradesh Govt launch AI radiology pilot in 10 district hospitals

At the center of deployment is mlHealth360’s proprietary Scaida AI platform, designed to detect and triage abnormalities in CT scans


Trialt and Viedoc team up to transform clinical trials
Clinical Trials | April 08, 2026

Trialt and Viedoc team up to transform clinical trials

The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide


OneCyte and Kemp Proteins to revolutionize cell line development
Biopharma | April 08, 2026

OneCyte and Kemp Proteins to revolutionize cell line development

Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules


Stipple Bio raises $100M Series A to advance next-gen cancer therapies
Biotech | April 08, 2026

Stipple Bio raises $100M Series A to advance next-gen cancer therapies

The new capital is expected to fund the company through 2029